Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 12.8 CNY -5.26% Market Closed
Market Cap: 28.5B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Yili Chuanning Biotechnology Co Ltd

Revenue
5.6B CNY
Cost of Revenue
-3.7B CNY
Gross Profit
1.9B CNY
Operating Expenses
-255.5m CNY
Operating Income
1.6B CNY
Other Expenses
-317.6m CNY
Net Income
1.3B CNY

Income Statement
Yili Chuanning Biotechnology Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
3 315
N/A
4 823
+46%
3 929
-19%
5 602
+43%
Gross Profit
Cost of Revenue
(2 517)
(3 343)
(2 618)
(3 712)
Gross Profit
798
N/A
1 480
+85%
1 312
-11%
1 889
+44%
Operating Income
Operating Expenses
(93)
(303)
(193)
(256)
Selling, General & Administrative
(44)
(208)
(140)
(184)
Research & Development
(38)
(50)
(48)
(60)
Depreciation & Amortization
0
(36)
0
0
Other Operating Expenses
(11)
(9)
(4)
(11)
Operating Income
705
N/A
1 177
+67%
1 119
-5%
1 634
+46%
Pre-Tax Income
Interest Income Expense
(79)
(57)
(50)
(68)
Non-Reccuring Items
(0)
0
0
(0)
Total Other Income
(19)
(2)
1
(8)
Pre-Tax Income
607
N/A
1 118
+84%
1 070
-4%
1 557
+46%
Net Income
Tax Provision
(103)
(177)
(168)
(241)
Income from Continuing Operations
504
941
902
1 316
Income to Minority Interest
0
(0)
(0)
(0)
Net Income (Common)
504
N/A
941
+87%
902
-4%
1 316
+46%
EPS (Diluted)
0.23
N/A
0.42
+83%
0.41
-2%
0.59
+44%

See Also

Discover More